This preparation phase involves selecting a highly active M2E biocatalyst, the engine of stereoselective conversion.
There is no product in the shopping cart, buy it!
β-D-glucopyranose is the core structural unit of cellulose and a fundamental monosaccharide. Its C2 epimer, β-D-mannopyranose, differs only in the configuration of the hydroxyl group at the C2 position. Systematic Chemoenzymatic offers a precise route to interconvert these sugars. The targeted, high-purity production of β-D-glucopyranose is essential for developing novel carbohydrate-based therapeutics and diagnostics, underpinning the credibility and specificity of cutting-edge glycoconjugate research. The production service utilizes the inherent biological reversibility between D-mannose and D-glucose, which are C2 epimers.
Core enzyme, substrate, and epimerization mechanism:
Your Next Breakthrough Starts Here - Inquire Now
Access to structurally precise carbohydrates is critical for advancing research in glycobiology, immunology, and drug development. Creative Biolabs provides tailor-made production of β-D-glucopyranose and its derivatives, moving beyond standard commercial offerings. We focus on producing this essential C2 epimer of mannose with high stereoselectivity and purity, essential for applications where subtle structural differences are paramount. Our production workflow utilizes biocatalysis for superior efficiency and stereocontrol, making it ideal for the precision required in carbohydrate chemistry.
This preparation phase involves selecting a highly active M2E biocatalyst, the engine of stereoselective conversion.
The goal of this stage is to establish the most efficient conversion protocol for the client's specific compound and scale requirement. We rigorously test critical parameters, including the titration of the β-D-mannopyranose substrate, optimal enzyme loading, cofactor requirements, and precise pH and temperature controls, thereby finalizing the optimized reaction parameters that guarantee high yield and successful scale-up.
This is the core manufacturing phase where the optimized protocol is executed within our controlled bioreactor environment. The β-D-mannopyranose substrate is mixed with the M2E catalyst, which drives the C2 epimerization to form the target β-D-glucopyranose. This process is monitored closely to ensure maximum conversion efficiency, yielding the crude reaction mixture containing the desired product.
In this essential stage, we isolate the target molecule by systematically removing all impurities, including residual M2E enzyme, unreacted substrate, and all reaction byproducts. This is achieved through proprietary sequential chromatographic techniques (such as ion exchange, size exclusion, and preparative HPLC), culminating in the final isolation of the target compound, typically as a high-purity crystalline solid or lyophilized powder.
Fig. 1 Production steps of high-purity β-D-glucopyranose.
Custom β-D-glucopyranose is used as a building block for the synthesis of complex C-, N-, or S-glycoside analogues, which are highly effective enzyme inhibitors or receptor agonists.
β-D-glucopyranose is an Essential component for preparing novel glycopeptides, glycolipids, and glycoproteins, used to study cell recognition, immune response, and vaccine design.
Labeled β-D-glucopyranose is the gold standard tracer for mapping metabolic pathways and elucidating the three-dimensional structures of carbohydrate-protein complexes via NMR spectroscopy.
Non-natural β-D-glucopyranose derivatives are used in the creation of specialized hydrogels, biocompatible polymers, and targeted delivery systems in nanomedicine.
Connect with Us for a Custom Solution - Request a Quote
A: Our biocatalytic approach using M2E offers superior stereocontrol, meaning you get the exact β-anomer configuration with exceptional purity. Chemical methods often yield complex mixtures that require tedious, low-yield separation. Let us discuss the exact derivative you need to highlight the specific advantages for your project.
A: The standard timeframe is 6 to 12 weeks. This depends mainly on the required scale, the complexity of the starting material sourcing, and whether chemical derivatization (post-enzymatic synthesis) is required. Contact us today with your project scope for a more precise timeline estimate.
A: Yes. We deliver the product in the form most suitable for your next step, often as a crystalline solid ready for direct use. If you require an activated form (e.g., a nucleotide sugar or a glycosyl donor), we offer subsequent chemical services to prepare the specific donor molecule you need. Let's discuss your synthetic route!
Scalable Synthesis
"Their M2E system's scalability facilitated the rapid transition from milligram lab synthesis to a multi-gram batch needed for our formulation work, which cut down our synthesis timeline by over a month. We found their pH and temperature control protocols during bioconversion to be meticulously documented." - Production Manager, P**r M.
Isotope Labeling Solution
"We needed C-6 deuterated β-D-glucopyranose for MS-based metabolism tracking. Creative Biolabs delivered the labeled compound with over 99% isotopic enrichment, something our previous chemical vendor could not achieve without high impurity levels. The application in our in vivo studies has been flawless." - Technical Supervisor, S**a H.
If your goal is to synthesize a larger, complex glycan structure, our β-D-glucopyranose product can immediately feed into our custom oligo synthesis platform.
If your internal research requires other glycosylation-related enzymes (Glycosyltransferases, Hydrolases, Epimerases), we offer custom enzyme cloning, expression, and purification services.
Once you have created your final glycoconjugate, our state-of-the-art analytical services can provide detailed N-glycan and O-glycan profiling, quantification, and linkage analysis to confirm structural integrity.
Creative Biolabs' custom β-D-glucopyranose production service is your strategic partner for obtaining high-purity, structurally defined carbohydrate building blocks. By leveraging advanced M2E biocatalysis, we mitigate the challenges of complexity, scale, and stereoselectivity inherent in carbohydrate chemistry, ensuring your research is built on the most reliable foundation. We are ready to translate your specific structural requirements into a tailored production plan that accelerates your drug discovery or basic research timeline. Reach out to our expert scientific team today to begin defining your custom synthesis project.